Theriva™ Biologics to Participate in the Q1 Investor Summit Virtual
Q1 Investor Summit Virtual Format: Presentation Presenter: Steve Shallcross, CEO and Manel Cascallo, PhD., General Director Presentation Date and Time: Tuesday, March 11, 2025, 12:30 PM ET Webcast: ...
cidrap.umn6d
Observational study shows efficacy of newer antibiotic in 'challenging clinical scenarios'
A study of 151 patients with carbapenem-nonsusceptible infections found treatment with imipenem/cilastatin/relebactam was ...
cidrap.umn6d
2 pet cats in Washington state get avian flu; 3 more detections in cattle
The owners told authorities that they fed their cats Wild Coast Raw pet food, the same brand implicated in recent feline ...
Too Old to Operate6d
Beta-Lactam Cross-Reactivity Variability and Its Impact on Clinical Decisions
The following is a summary of “Discrepancies in Beta-Lactam Antibiotics Cross-Reactivity: Implications for Clinical Practice,” published in the February 2025 issue of European Journal of Allergy and ...